Now Playing

Actos and its link to bladder cancer discussed by Beasley Allen attorney Andy Birchfield

posted on:
May 20, 2014


This week on the Beasley Allen Report, host Gibson Vance welcomes Beasley Allen lawyer Andy Birchfield. Birchfield is head of Beasley Allen’s Mass Torts section, which is currently working on cases involving the drug Actos and its link to bladder cancer. Actos, manufactured by Takeda Pharmaceuticals, was issued a warning by the FDA saying people who have been taking the drug for a year or longer have an increased risk of developing bladder cancer. Interim results from a 10-year American study found long-term Actos users had 40 percent more bladder cancers than people who never took the drug. Bladder cancer kills about 15,000 people per year in the U.S. The drug also may be linked to congestive heart failure.

To learn more about Actos and its deadly side-effects, please visit our Actos website at

Courtesy of: Beasley Allen Report

back to top